Dunnigan familial partial lipodystrophy
| Dunnigan familial partial lipodystrophy | |
|---|---|
| Classification and external resources | |
| Specialty | Lua error in Module:Wikidata at line 446: attempt to index field 'wikibase' (a nil value). |
| OMIM | 151660 |
| Patient UK | Dunnigan familial partial lipodystrophy |
Dunnigan-type familial partial lipodystrophy, abbreviated as (FPLD), is a rare monogenic form of insulin resistance characterized by loss of subcutaneous fat from the extremities, trunk, and gluteal region. FPLD recapitulates the main metabolic attributes of the insulin resistance syndrome, including central obesity, hyperinsulinemia, glucose intolerance and diabetes[1] usually type 2,[2] dyslipidemia, hypertension,[1] and early endpoints of atherosclerosis.[2] It can also result in hepatic steatosis.[3] FPLD results from mutations in LMNA gene, which is the gene that encodes nuclear lamins A and C.[1]
See also
References
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about an endocrine, nutritional or metabolic disease is a stub. You can help Wikipedia by expanding it. |
